OA05.02 Epacadostat Plus Pembrolizumab in Patients With Non-Small Cell Lung Cancer: Phase 1/2 Results From ECHO-202/KEYNOTE-037

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.258
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Epacadostat Plus Pembrolizumab Is Well Tolerated in a Phase I Trial

Cancer Discovery
Oncology
2018English

P1.01-12 SWItch Maintenance PEmbrolizumab in Patients With Metastatic Non Small Cell Lung Cancer (SWIPE)

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Motesanib Plus Carboplatin/Paclitaxel in Patients With Advanced Squamous Non–Small-Cell Lung Cancer: Results From the Randomized Controlled MONET1 Study

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2014English

Gemcitabine Plus Vinorelbine in Elderly or Unfit Patients With Non-Small Cell Lung Cancer

British Journal of Cancer
Cancer ResearchOncology
2000English

Ceritinib Plus Nivolumab in Patients With Advanced ALK-rearranged Non-Small-Cell Lung Cancer: Results of an Open-Label, Multicenter, Phase 1B Study

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2020English

P1.01-13 a Study of S-1 Plus Cisplatin in Patients With Advanced Non-Small-Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P1.01-32 a Multicenter, Open-Label, Phase II Trial of S-1 Plus Carboplatin in Advanced Non-Small Cell Lung Cancer Patients With Interstitial Lung Disease

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Pembrolizumab-Induced Obstructive Bronchiolitis in a Patient With Stage IV Non-Small-Cell Lung Cancer

Current Oncology
Oncology
2019English

Cost-Effectiveness Analysis of Pembrolizumab Plus Chemotherapy for Previously Untreated Metastatic Non-Small Cell Lung Cancer in the USA

BMJ Open
Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy